FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald Maurice

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Rats

Physiology

Signal Transduction

Co-author Network

Publications

TOP 3
Donald H Maurice
PDE8A runs interference to limit PKA inhibition of Raf-1.
Thomas K Hamilton; Nianping Hu; Klodiana Kolomitro; Donald H Maurice; Erin N Bell; Charles H Graham; D Robert Siemens
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.
Donald H Maurice
Subcellular signaling in the endothelium: cyclic nucleotides take their place.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald Maurice (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Donald H Maurice
PDE8A runs interference to limit PKA inhibition of Raf-1.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(16):6248-9.
2013: Thomas K Hamilton; Nianping Hu; Klodiana Kolomitro; Donald H Maurice; Erin N Bell; Charles H Graham; D Robert Siemens
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.
World journal of urology 2013;31(2):325-30.
2011: Donald H Maurice
Subcellular signaling in the endothelium: cyclic nucleotides take their place.
Current opinion in pharmacology 2011;11(6):656-64.
2011: Sanja Beca; S R Wayne Chen; Marco Conti; Gerrie P Farman; Peter B Helli; Peter P Jones; Vincent Manganiello; Donald H Maurice; Matthew A Movsesian; Jeremy A Simpson; Xixi Tian; Lindsay S Wilson; Dongling Zhao; Faiyaz Ahmad; Peter H Backx
Phosphodiesterase 4D regulates baseline sarcoplasmic reticulum Ca2+ release and cardiac contractility, independently of L-type Ca2+ current.
Circulation research 2011;109(9):1024-30.
2008: Lindsay S Wilson; Hisham S Elbatarny; Scott W Crawley; Brian M Bennett; Donald H Maurice
Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(36):13650-5.
2007: Daniel R Raymond; Lindsay S Wilson; Rhonda L Carter; Donald H Maurice
Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion.
Cellular signalling 2007;19(12):2507-18.
2007: Stuart J Netherton; Jayda A Sutton; Lindsay S Wilson; Rhonda L Carter; Donald H Maurice
Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells.
Circulation research 2007;101(8):768-76.
2007: Benoit-Gilles Kerfant; Dongling Zhao; Ilka Lorenzen-Schmidt; Lindsay S Wilson; Shitian Cai; S R Wayne Chen; Donald H Maurice; Peter H Backx
PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes.
Circulation research 2007;101(4):400-8.
2007: Emilia Furmaniak-Kazmierczak; Scott W Crawley; Rhonda L Carter; Donald H Maurice; Graham P Côté
Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells.
Circulation research 2007;100(9):1328-36.
2007: Daniel Palmer; Sandra L Jimmo; Daniel R Raymond; Lindsay S Wilson; Rhonda L Carter; Donald H Maurice
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation.
The Journal of biological chemistry 2007;282(13):9411-9.
2007: Hisham S Elbatarny; Stuart J Netherton; Jeffrey D Ovens; Alastair V Ferguson; Donald H Maurice
Adiponectin, ghrelin, and leptin differentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases.
European journal of pharmacology 2007;558(1-3):7-13.
2006: Jeffery D MacPherson; Timothy D Gillespie; Heather A Dunkerley; Donald H Maurice; Brian M Bennett
Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
The Journal of pharmacology and experimental therapeutics 2006;317(1):188-95.
2005: Hisham S Elbatarny; Donald H Maurice
Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex.
American journal of physiology. Endocrinology and metabolism 2005;289(4):E695-702.
2005: Douglas G Tilley; Donald H Maurice
Vascular smooth muscle cell phenotype-dependent phosphodiesterase 4D short form expression: role of differential histone acetylation on cAMP-regulated function.
Molecular pharmacology 2005;68(3):596-605.
2005: Donald H Maurice
Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
Frontiers in bioscience : a journal and virtual library 2005;10():1221-8.
2005: Stuart J Netherton; Donald H Maurice
Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Molecular pharmacology 2005;67(1):263-72.
2004: Donald H Maurice
Cardiovascular implications in the use of PDE5 inhibitor therapy.
International journal of impotence research 2004;16 Suppl 1():S20-3.
2003: Donald H Maurice; Daniel Palmer; Douglas G Tilley; Heather A Dunkerley; Stuart J Netherton; Daniel R Raymond; Hisham S Elbatarny; Sandra L Jimmo
Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system.
Molecular pharmacology 2003;64(3):533-46.
2003: Donald H Maurice
Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes.
Proceedings of the Western Pharmacology Society 2003;46():32-6.
2002: Douglas G Tilley; Donald H Maurice
Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Molecular pharmacology 2002;62(3):497-506.
2002: Heather A Dunkerley; Douglas G Tilley; Daniel Palmer; Hanguan Liu; Sandra L Jimmo; Donald H Maurice
Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues.
Molecular pharmacology 2002;61(5):1033-40.
2002: Stuart J Netherton; Sandra L Jimmo; Daniel Palmer; Douglas G Tilley; Heather A Dunkerley; Daniel R Raymond; James C Russell; P Marlene Absher; E Helene Sage; Robert B Vernon; Donald H Maurice
Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Diabetes 2002;51(4):1194-200.
2000: Hanguan Liu; Daniel Palmer; Sandra L Jimmo; Douglas G Tilley; Heather A Dunkerley; Stephen C Pang; Donald H Maurice
Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells.
The Journal of biological chemistry 2000;275(34):26615-24.
2000: Daniel Palmer; Donald H Maurice
Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
Molecular pharmacology 2000;58(2):247-52.
1999: Scott D Appleton; M L Chretien; Brian E McLaughlin; Hendrik J Vreman; David K Stevenson; James F Brien; Kanji Nakatsu; Donald H Maurice; Gerald S Marks
Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(10):1214-9.
1999: Hanguan Liu; Donald H Maurice
Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting.
The Journal of biological chemistry 1999;274(15):10557-65.
1998: Hanguan Liu; Donald H Maurice
Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
British journal of pharmacology 1998;125(7):1501-10.
1998: Daniel Palmer; K Tsoi; Donald H Maurice
Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.
Circulation research 1998;82(8):852-61.
1998: Donald H Maurice
Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Cell biochemistry and biophysics 1998;29(1-2):35-47.
1997: R J Rose; Hanguan Liu; Daniel Palmer; Donald H Maurice
Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
British journal of pharmacology 1997;122(2):233-40.
1997: Michael A Adams; J D Banting; Donald H Maurice; Alvaro Morales; Jeremy P W Heaton
Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems.
International journal of impotence research 1997;9(2):85-91.
1997: AS Hussain; J Bozinovski; Donald H Maurice; Brian E McLaughlin; Gerald S Marks; James F Brien; Kanji Nakatsu
Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Canadian journal of physiology and pharmacology 1997;75(5):398-406.
1996: Y A Senis; M Richardson; S Tinlin; Donald H Maurice; Alan Giles
Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo.
British journal of haematology 1996;93(1):195-203.
1995: Donald H Maurice; Y A Senis; Hanguan Liu; Alan Giles; E H Horn
Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: molecular cloning using isolated cell layers from paraformaldehyde-fixed tissues.
Journal of pharmacological and toxicological methods 1995;34(3):175-85.
1993: Z Liu; Kanji Nakatsu; James F Brien; E D Beaton; Gerald S Marks; Donald H Maurice
Selective sequestration of nitric oxide by subcellular components of vascular smooth muscle and platelets: relationship to nitric oxide stimulation of the soluble guanylyl cyclase.
Canadian journal of physiology and pharmacology 1993;71(12):938-45.